Glycopyrrolate Injection 0.2 mg is an anticholinergic medication used to reduce secretions, prevent bradycardia during surgery, and manage peptic ulcers and hypersalivation in clinical and hospital settings.
Brand Name: GLYCOPYRROLATE
Generic Name: Glycopyrrolate Injection
Available Strengths:
Glycopyrrolate Injection 0.2 mg
Glycopyrrolate Injection is a fast-acting anticholinergic agent widely used in hospital and surgical settings. It works by inhibiting muscarinic receptors, effectively reducing salivary, tracheobronchial, and gastric secretions, and preventing bradycardia during anesthesia. Glycopyrrolate is also used in managing peptic ulcers, hypersalivation, and certain respiratory conditions. Administered intravenously or intramuscularly under strict medical supervision, it provides rapid and reliable action, ensuring patient safety and comfort during procedures. Its precise dosing, quick onset, and predictable effects make Glycopyrrolate Injection 0.2 mg an essential medicine in operative, critical care, and emergency applications.
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com
